FULGENT GENETICS, INC. Proceeds from Contributed Capital
FULGENT GENETICS, INC. (FLGT) reported Proceeds from Contributed Capital of $3.50 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2017-03-17
- FULGENT GENETICS, INC. proceeds from contributed capital for the quarter ending 2015-12-31 was $0.00.
- FULGENT GENETICS, INC. proceeds from contributed capital for fiscal 2015 was $3.50M, a 12.50% decline from fiscal 2014.
- FULGENT GENETICS, INC. proceeds from contributed capital for fiscal 2014 was $4.00M.
| Period end | Proceeds from Contributed Capital 3 month | Proceeds from Contributed Capital 9 month | Proceeds from Contributed Capital 12 month |
|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | $3.50M 10-K · filed 2017-03-17 | |
| 2015-09-30 | $3.50M 10-Q · filed 2016-11-14 | ||
| 2014-12-31 | $4.00M 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |